Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amicus Therapeutics (FOLD) Debt Ratio (2016 - 2023)

Historic Debt Ratio for Amicus Therapeutics (FOLD) over the last 15 years, with Q2 2023 value amounting to 0.02.

  • Amicus Therapeutics' Debt Ratio fell 2597.98% to 0.02 in Q2 2023 from the same period last year, while for Jun 2023 it was 0.02, marking a year-over-year decrease of 2597.98%. This contributed to the annual value of 0.03 for FY2022, which is 4163.61% up from last year.
  • As of Q2 2023, Amicus Therapeutics' Debt Ratio stood at 0.02, which was down 2597.98% from 0.02 recorded in Q1 2023.
  • In the past 5 years, Amicus Therapeutics' Debt Ratio registered a high of 0.21 during Q2 2020, and its lowest value of 0.01 during Q4 2020.
  • In the last 5 years, Amicus Therapeutics' Debt Ratio had a median value of 0.03 in 2021 and averaged 0.08.
  • Its Debt Ratio has fluctuated over the past 5 years, first surged by 143767.5% in 2019, then plummeted by 9420.83% in 2020.
  • Quarter analysis of 5 years shows Amicus Therapeutics' Debt Ratio stood at 0.17 in 2019, then crashed by 94.21% to 0.01 in 2020, then soared by 107.99% to 0.02 in 2021, then surged by 41.64% to 0.03 in 2022, then tumbled by 39.77% to 0.02 in 2023.
  • Its Debt Ratio was 0.02 in Q2 2023, compared to 0.02 in Q1 2023 and 0.03 in Q4 2022.